AstraZeneca PLC (AZN) vs T-Mobile US, Inc. (TMUS)
TMUS leads on 9 of 17 compared metrics.
A side-by-side comparison of AstraZeneca PLC and T-Mobile US, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 15, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
AZN
AstraZeneca PLC
$178.75Healthcare
TMUS
T-Mobile US, Inc.
$189.10Communication Services
Total return — AZN vs TMUS
growth of $100 · last 19yAZN +210.0%TMUS +245.1%TMUS compounded faster
AZN TMUS
AZN vs TMUS: by the numbers
- •AZN is the larger company ($277.22B vs $204.64B market cap).
- •TMUS trades at the lower earnings multiple (20.12 vs 26.92 P/E).
- •AZN converts more revenue to profit (17.19% vs 11.65% net margin).
- •AZN grew revenue faster over the past five years (16.99% vs 3.28% CAGR).
- •TMUS pays the higher dividend yield (2.08% vs 1.79%).
Which is better, AZN or TMUS?
Metric tally: AZN 8 · TMUS 9It depends on what you're optimizing for:
ValueTMUS(lower P/E)
GrowthAZN(faster 5Y revenue CAGR)
IncomeTMUS(higher dividend yield)
QualityAZN(higher ROIC)
Metrics side by side
Valuation
| Metric | AZN | TMUS |
|---|---|---|
| P/E ratio | 26.92 | 20.12● |
| Forward P/E | 15.33 | 13.93● |
| P/S ratio | 4.62 | 2.30● |
| P/B ratio | 5.90 | 3.73● |
| PEG ratio | 0.14● | 40.42 |
| EV / EBITDA | 14.92 | 11.58● |
| FCF yield | 2.89% | 7.50%● |
Profitability
| Metric | AZN | TMUS |
|---|---|---|
| Gross margin | 81.68%● | 54.34% |
| Operating margin | 23.69%● | 20.36% |
| Net margin | 17.19%● | 11.65% |
| ROE | 21.95%● | 18.87% |
| ROIC | 13.03%● | 7.04% |
Dividends
| Metric | AZN | TMUS |
|---|---|---|
| Dividend yield | 1.79% | 2.08%● |
| Payout ratio | 48.48% | 40.41% |
Growth (annualized)
| Metric | AZN | TMUS |
|---|---|---|
| Revenue CAGR (5Y) | 16.99%● | 3.28% |
| EPS CAGR (5Y) | 22.02% | 29.48%● |
| FCF CAGR (5Y) | 15.68% | 42.72%● |
| Total return CAGR (5Y) | 11.03%● | 6.34% |
Frequently asked
- Which is better, AZN or TMUS?
- It depends on your goal. value: TMUS (lower P/E); growth: AZN (faster 5Y revenue CAGR); income: TMUS (higher dividend yield); quality: AZN (higher ROIC). Across all compared metrics, TMUS leads 9 to 8.
- Is AZN or TMUS cheaper?
- On trailing earnings, TMUS is cheaper: AZN trades at a 26.92 P/E and TMUS at 20.12.
- Which has grown faster, AZN or TMUS?
- Over the past five years, AZN grew revenue faster — AZN at a 16.99% CAGR versus TMUS at 3.28%.
- Does AZN or TMUS pay a bigger dividend?
- AZN yields 1.79% and TMUS yields 2.08% based on trailing dividends and the latest price.
- Is AZN or TMUS more profitable?
- AZN runs the higher net margin — AZN at 17.19% versus TMUS at 11.65%.
- Which has been the better investment, AZN or TMUS?
- Over the past 10-year, TMUS delivered the higher annualized total return — AZN at 15.77% versus TMUS at 16.76%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AstraZeneca P/E ratioT-Mobile US P/E ratioAstraZeneca dividend yieldT-Mobile US dividend yieldAstraZeneca ROET-Mobile US ROEAstraZeneca operating marginT-Mobile US operating marginAstraZeneca revenue growthT-Mobile US revenue growthAstraZeneca free cash flowT-Mobile US free cash flow
AstraZeneca & T-Mobile US appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 15, 2026.